1-3
2026
影响因子区间
—
平台估算
59%
2025
中国作者发文占比
1800 EUR
收费
期刊简介:Current Cancer Drug Targets aims to cover all the latest and outstanding developments on the medicinal chemistry, pharmacology, molecular biology, genomics and biochemistry of contemporary molecular drug targets involved in cancer, e.g. disease specific proteins, receptors, enzymes and genes.Current Cancer Drug Targets publishes original research articles, letters, reviews / mini-reviews, drug clinical trial studies and guest edited thematic issues written by leaders in the field covering a range of current topics on drug targets involved in cancer.As the discovery, identification, characterization and validation of novel human drug targets for anti-cancer drug discovery continues to grow; this journal has become essential reading for all pharmaceutical scientists involved in drug discovery and development.
【译文】当前癌症药物靶点旨在涵盖所有关于当代分子药物靶点在癌症中的最新和杰出发展,例如疾病特异性蛋白质、受体、酶和基因。当前癌症药物靶点发表原创研究文章、信件、综述/迷你综述、药物临床试验研究和由该领域领导者撰写的主题特刊,涵盖涉及癌症药物靶点的当前一系列主题。随着新型人药物靶点的发现、鉴定、特征描述和验证在抗癌药物发现中不断增长;这本期刊已成为所有参与药物发现和开发的制药科学家必读之物。

| 指标 | 当前值 | 近三年趋势 |
|---|---|---|
| JCR分区 | Q3 | 暂无 |
| 中科院分区 | 4区 | 暂无 |
| 影响因子区间 | 1-3 | 暂无 |